Clever Leaves Holdings Inc, a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, has made its first commercial export to Israel.
Clever Leaves is exporting high THC flower for medical use from its facility in Portugal through its partnership with Israeli cannabis company InterCure, the fastest-growing cannabis company outside of North America.
With this initial shipment, medical cannabis patients in Israel will now have access to the company’s cannabis flower which is grown in its IMC-GAP equivalent cultivation facilities.
Clever Leaves will first supply InterCure with a high THC strain followed by several other genetics that will come as part of a long-term partnership agreement between the companies.
“Our partnership with InterCure has been a long time in the making and we are thrilled to be working with one of the most prominent names in Israeli medical cannabis,” said Andrés Fajardo, CEO of Clever Leaves.
“Israel has been a strategic market focus for Clever Leaves and InterCure’s position as a market leader further solidifies our plans for growth in the region. In addition to this being representative of our continued global expansion, it proves that our products can meet the most stringent regulatory standards in the world.”
Clever Leaves will cultivate proprietary genetics for Canndoc – a wholly-owned subsidiary of InterCure – in its Colombia and Portugal facilities for distribution across Israel and other countries.
Canndoc is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
Alex Rabinovitch, CEO of InterCure, said: “We’re delighted to see the first fruit of our successful partnership with Clever Leaves. This first importation is just the first step for our long-term partnership and an attestment to the abilities of our teams to meet the challenging strict regulatory requirements of the Israeli pharmaceutical-grade medical cannabis market.”
Clever Leaves said it aims to disrupt the traditional cannabis production industry by leveraging environmentally sustainable, ESG-friendly, industrial-scale and low-cost production methods.
